Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1217)
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
406
Price
$71.66
Total Value
$29.09K
Shares Held After
181,371
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
994
Price
$70.45
Total Value
$70.03K
Shares Held After
181,777
% of Holdings
0.5%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
300
Price
$69.43
Total Value
$20.83K
Shares Held After
182,771
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
300
Price
$68.27
Total Value
$20.48K
Shares Held After
183,071
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
37
Price
$332.64
Total Value
$12.31K
Shares Held After
36,606
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
94
Price
$331.93
Total Value
$31.20K
Shares Held After
36,643
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
81
Price
$330.85
Total Value
$26.80K
Shares Held After
36,737
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
170
Price
$329.71
Total Value
$56.05K
Shares Held After
36,818
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
100
Price
$328.71
Total Value
$32.87K
Shares Held After
36,988
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
329
Price
$327.67
Total Value
$107.80K
Shares Held After
37,088
% of Holdings
0.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
392
Price
$326.81
Total Value
$128.11K
Shares Held After
37,417
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
258
Price
$325.63
Total Value
$84.01K
Shares Held After
37,809
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
90
Price
$324.65
Total Value
$29.22K
Shares Held After
38,067
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
47
Price
$323.62
Total Value
$15.21K
Shares Held After
38,157
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
160
Price
$332.64
Total Value
$53.22K
Shares Held After
98,628
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
399
Price
$331.93
Total Value
$132.44K
Shares Held After
98,788
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
346
Price
$330.85
Total Value
$114.47K
Shares Held After
99,187
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
722
Price
$329.71
Total Value
$238.05K
Shares Held After
99,533
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
424
Price
$328.71
Total Value
$139.37K
Shares Held After
100,255
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
1,399
Price
$327.67
Total Value
$458.41K
Shares Held After
100,679
% of Holdings
1.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
1,669
Price
$326.81
Total Value
$545.45K
Shares Held After
102,078
% of Holdings
1.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
1,098
Price
$325.63
Total Value
$357.54K
Shares Held After
103,747
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
382
Price
$324.65
Total Value
$124.02K
Shares Held After
104,845
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
200
Price
$323.62
Total Value
$64.72K
Shares Held After
105,227
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
37
Price
$332.64
Total Value
$12.31K
Shares Held After
23,512
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
94
Price
$331.93
Total Value
$31.20K
Shares Held After
23,549
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
81
Price
$330.85
Total Value
$26.80K
Shares Held After
23,643
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
170
Price
$329.71
Total Value
$56.05K
Shares Held After
23,724
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
100
Price
$328.71
Total Value
$32.87K
Shares Held After
23,894
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
329
Price
$327.67
Total Value
$107.80K
Shares Held After
23,994
% of Holdings
1.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
392
Price
$326.81
Total Value
$128.11K
Shares Held After
24,323
% of Holdings
1.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
258
Price
$325.63
Total Value
$84.01K
Shares Held After
24,715
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
90
Price
$324.65
Total Value
$29.22K
Shares Held After
24,973
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
47
Price
$323.62
Total Value
$15.21K
Shares Held After
25,063
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
53
Price
$332.64
Total Value
$17.63K
Shares Held After
64,273
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
129
Price
$331.93
Total Value
$42.82K
Shares Held After
64,326
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
112
Price
$330.85
Total Value
$37.06K
Shares Held After
64,455
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
234
Price
$329.71
Total Value
$77.15K
Shares Held After
64,567
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
138
Price
$328.71
Total Value
$45.36K
Shares Held After
64,801
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
454
Price
$327.67
Total Value
$148.76K
Shares Held After
64,939
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
541
Price
$326.81
Total Value
$176.80K
Shares Held After
65,393
% of Holdings
0.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
356
Price
$325.63
Total Value
$115.92K
Shares Held After
65,934
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
124
Price
$324.65
Total Value
$40.26K
Shares Held After
66,290
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
65
Price
$323.62
Total Value
$21.04K
Shares Held After
66,414
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
42
Price
$332.64
Total Value
$13.97K
Shares Held After
25,181
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
101
Price
$331.93
Total Value
$33.52K
Shares Held After
25,223
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
87
Price
$330.85
Total Value
$28.78K
Shares Held After
25,324
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
182
Price
$329.71
Total Value
$60.01K
Shares Held After
25,411
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
107
Price
$328.71
Total Value
$35.17K
Shares Held After
25,593
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
353
Price
$327.67
Total Value
$115.67K
Shares Held After
25,700
% of Holdings
1.4%
Showing 1001–1050 of 1217 transactions (page 21 of 25)